Reduction of sialic acids on B16 cells by silencing the CMP-sialic acid transporter Slc35a1 slowed down tumor growth in vivo and promoted an anti-tumor immune response, boosting the tumor infiltration of effector T cells and decreasing the frequency of T regulatory cells. This evidence concerns the gene SLC35A1 and neoplasm.